Several clinical trials of ATM inhibitors are ongoing, but only one Phase I trial has concluded, studying the safety and preliminary efficacy of AZD0156 alone or in combination with other anticancer treatments in patients with advanced cancer. The gene discussed is ATM; the disease is cancer.